Pfizer’s Hympavzi secures FDA expanded indications for haemophilia Hospital Management 10:45 Tue, 09 Jun
Pfizer scores FDA pediatric expansion for hemophilia treatment Hympavzi FiercePharma 15:39 Mon, 08 Jun
Pfizer: FDA Expands Hympavzi Approval To Pediatric And Inhibitor Hemophilia Patients RTT News 13:52 Mon, 08 Jun
Pfizer Says FDA Approves Expanded Hympavzi Indication For Hemophilia A And B RTT News 12:20 Mon, 08 Jun
U.S. FDA Approves Pfizer’s Hympavzi for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need Business Wire (Press Release) 11:47 Mon, 08 Jun
European Commission Approves Pfizer’s Hympavzi for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors Business Wire (Press Release) 11:49 Wed, 13 May
